| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/17/2014 | US20140200217 Smoothened antagonism for the treatment of hedgehog pathway-related disorders |
| 07/17/2014 | US20140200197 Hiv protease inhibitors |
| 07/17/2014 | US20140200188 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 07/17/2014 | US20140199415 Pharmaceutical combination comprising a cip2a silencing agent for use in the treatment of a hyperproliferative disorder, preferably one with impaired p53 function |
| 07/17/2014 | US20140199411 Therapeutic agent for emphysema and copd |
| 07/17/2014 | US20140199408 Therapeutic stem cell nutrient composition and uses thereof |
| 07/17/2014 | US20140199399 Use of tgf-beta antagonists to treat infants at risk of developing bronchopulmonary dysplasia |
| 07/17/2014 | US20140199377 Multiple growth factor compositions, methods of fabrication, and methods of treatment |
| 07/17/2014 | US20140199375 Combination therapy for skin disorders |
| 07/17/2014 | US20140199367 Topical Transdermal Method for Delivering Nutrients Through the Skin for Expeditied Wound Healing and Skin Rejuvenation |
| 07/17/2014 | US20140199329 Methods for treating and preventing neutrophil-derived net toxicity and thrombosis |
| 07/17/2014 | US20140199323 Monoclonal Antibody |
| 07/17/2014 | US20140199312 DDR1-Binding Agents and Methods of Use Thereof |
| 07/17/2014 | US20140199310 Compositions comprising agents that inhibit neuropilin and tolloid like 2 |
| 07/17/2014 | US20140199292 Compositions and methods for inhibiting tumor development caused by chemotherapy induced senescence |
| 07/17/2014 | US20140199287 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 07/17/2014 | US20140199266 Honey nasal rinse |
| 07/17/2014 | US20140199264 Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases |
| 07/17/2014 | US20140199263 Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases |
| 07/17/2014 | US20140199261 Method of reducing multi-drug resistance using inositol tripyrophosphate |
| 07/17/2014 | US20140199234 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same |
| 07/16/2014 | EP2754719A1 Method of applying etfb to abnormal proliferation of cell, and abnormal proliferation inhibitor |
| 07/16/2014 | EP2754713A1 ANTIBODY AGAINST MUTANT alpha-ACTININ-4 |
| 07/16/2014 | EP2754660A1 Pyridazinon derivatives |
| 07/16/2014 | EP2754454A2 Non-steroidal anti-inflammatory drug derivatives |
| 07/16/2014 | EP2754448A2 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury |
| 07/16/2014 | EP2754445A2 Electricity-generating particulates for use in excessive sweating |
| 07/16/2014 | EP2753336A1 Compositions comprising s-adenosylmethionine and a gallic acid ester |
| 07/16/2014 | CN103930545A 淀粉样蛋白球体结合并诱发成熟神经细胞死亡的靶向分子、用于抑制淀粉样蛋白球体诱导的神经细胞死亡的方法和物质以及它们的用途 Binding and amylospheroids induce neuronal cell death of mature targeting molecules, methods and materials for inhibiting amyloid-induced neuronal cell death spheres and their use |
| 07/16/2014 | CN103930132A 治疗胶质瘤的组合物和方法 The compositions and methods of treatment of glioma |
| 07/16/2014 | CN103930111A 包含c-met拮抗剂和b-raf拮抗剂的组合治疗 Contains the c-met antagonist and b-raf antagonist combination therapy |
| 07/16/2014 | CN103920151A 一种治疗糖尿病慢性并发症的组合物 A method of treating chronic complications of diabetes compositions |
| 07/16/2014 | CN103920150A Satb1在治疗皮肤t细胞淋巴瘤中的应用 Satb1 used in the treatment of cutaneous t-cell lymphoma |
| 07/16/2014 | CN103920149A 一种壳聚糖光敏微球的制备方法 A photosensitive preparation of chitosan microspheres |
| 07/16/2014 | CN103919924A 一种瑞香狼毒提取物口服液 One kind of oral liquid extract Stellera chamaejasme |
| 07/16/2014 | CN103919804A 治疗消化功能紊乱的组合物和方法 Treatment of digestive disorders compositions and methods |
| 07/16/2014 | CN103099782B 核-壳型纳米药物颗粒、其制备方法及应用 Core - shell nano drug particles, their preparation and application |
| 07/16/2014 | CN102370981B 防治神经退行性疾病的试剂和方法 Reagents and methods of prevention and treatment of neurodegenerative diseases |
| 07/16/2014 | CN102325905B 伊立替康的敏感性判断方法及其利用 Irinotecan determine the sensitivity of the method and its use |
| 07/16/2014 | CN101674810B 针对癌细胞和癌相关成纤维细胞的靶向剂 For cancer cells and cancer-associated fibroblasts targeting agent |
| 07/16/2014 | CN101166543B 含抗痴呆药物的组合物 Compositions containing anti-dementia drugs |
| 07/15/2014 | US8779189 High protein supplement |
| 07/15/2014 | US8779171 Hydroxamates as therapeutic agents |
| 07/15/2014 | US8779141 Viral inhibitors |
| 07/15/2014 | US8779099 MIF antagonists |
| 07/15/2014 | US8779098 B7-H3L cell surface antigen and antibodies that bind thereto |
| 07/15/2014 | US8778999 Non-steroidal anti-inflammatory ophthalmic compositions |
| 07/15/2014 | US8778962 Treatment of solid tumors with rapamycin derivatives |
| 07/15/2014 | US8778961 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/15/2014 | US8778921 Ansamycin hydroquinone compositions |
| 07/15/2014 | US8778902 RNA interference mediating small RNA molecules |
| 07/15/2014 | US8778873 Parenteral combination therapy for infective conditions with drug resistant bacterium |
| 07/15/2014 | US8778404 Nutritional compositions |
| 07/15/2014 | US8778403 Diketopiperazine microparticles with defined specific surface areas |
| 07/15/2014 | US8778384 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals |
| 07/15/2014 | US8778347 Fluorescent neutralization and adherence inhibition assays |
| 07/15/2014 | US8778324 Ion binding polymers and uses thereof |
| 07/15/2014 | CA2782510C Polypeptides |
| 07/15/2014 | CA2606887C Pharmaceutical composition |
| 07/15/2014 | CA2548305C Use of alginate matrices to control cell growth |
| 07/15/2014 | CA2496485C Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis |
| 07/15/2014 | CA2484303C Salt solution for colon cleansing |
| 07/10/2014 | WO2014107572A1 Body surface treatment composition and method |
| 07/10/2014 | WO2014106623A1 C-terminal hsp90 inhibitors to treat pituitary adenomas |
| 07/10/2014 | US20140194516 Medicaments Containing Pantothenic Acid |
| 07/10/2014 | US20140194515 Use of a Composition Comprising an Antacid, a Mucolytic and a Gelling Agent in the Treatment of Cold |
| 07/10/2014 | US20140194496 Methods and compositions for inhibiting integrins using tellurium-containing compounds |
| 07/10/2014 | US20140194476 Pyridone derivatives and their use in the treatment, ameloriation or prevention of a viral disease |
| 07/10/2014 | US20140194471 Substituted 1-benzylindolin-2-one analogs as positive allosteric modulators of muscarinic acetylcholine m1 receptors |
| 07/10/2014 | US20140194459 Method and composition for treating an alpha adrenoceptor-mediated condition |
| 07/10/2014 | US20140194457 Carboxamide bioisosteres of opiates |
| 07/10/2014 | US20140194456 Abuse-resistant controlled-release opioid dosage form |
| 07/10/2014 | US20140194439 Methods of targeted drug development |
| 07/10/2014 | US20140194432 Naphthyridinone derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 07/10/2014 | US20140194431 Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 07/10/2014 | US20140194430 Substituted aminoimidazopyridazines |
| 07/10/2014 | US20140194427 Deuterium Substituted Fumarate Derivatives |
| 07/10/2014 | US20140194419 Chromenone derivatives |
| 07/10/2014 | US20140194415 Fatty acid synthase inhibitors |
| 07/10/2014 | US20140194408 Heteroaryl pyridone and aza-pyridone compounds |
| 07/10/2014 | US20140194406 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors |
| 07/10/2014 | US20140194399 Use of pufas for treating skin inflammation |
| 07/10/2014 | US20140194385 Boronic acid derivatives and therapeutic uses thereof |
| 07/10/2014 | US20140194384 Boronic acid derivatives and therapeutic uses thereof |
| 07/10/2014 | US20140194382 Boronic acid derivatives and therapeutic uses thereof |
| 07/10/2014 | US20140194381 Boronic acid derivatives and therapeutic uses thereof |
| 07/10/2014 | US20140194380 Method of manufacturing composition comprising local anesthetic, heparinoid, and buffer |
| 07/10/2014 | US20140194370 Silk-elastin like protein polymers for embolization and chemoembolization to treat cancer |
| 07/10/2014 | US20140194349 HIV Protease Inhibiting Compounds |
| 07/10/2014 | US20140194344 Fusion peptide designed to reduce plaque bacteria and yeast in the oral cavity |
| 07/10/2014 | US20140193517 Method of drug repositioning |
| 07/10/2014 | US20140193490 Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| 07/10/2014 | US20140193488 In Situ Antigen-Generating Cancer Vaccine |
| 07/10/2014 | US20140193466 Silk compositions and methods of using same |
| 07/10/2014 | US20140193458 Method of vaccination comprising a histone deacetylase inhibitor |
| 07/10/2014 | US20140193399 Anti-CD3 Antibodies And Methods Of Use Thereof |
| 07/10/2014 | US20140193393 Methods for Treatment of Stroke or Cerebrovascular Accidents Using an ETB Receptor Agonist |
| 07/10/2014 | US20140193382 Endogenous Expression of HLA-G and/or HLA-E by Mesenchymal Cells |
| 07/10/2014 | US20140193358 Treating cancer stem cells using targeted cargo proteins |
| 07/10/2014 | US20140193345 Herbal compositions for the treatment of mucosal lesions |